Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 5.14% is 74% below its 5-year average of 19.60%, near the low end of its 5-year range (5.14%–33.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 33.20% below its 12-month average of 7.69%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.14%.
DEBT TO ASSETS RATIO
5.14%
DEBT TO ASSETS RATIO AVG TTM
7.69%
DEBT TO ASSETS RATIO AVG 3Y
14.38%
DEBT TO ASSETS RATIO AVG 5Y
19.60%
DEBT TO ASSETS RATIO AVG 10Y
12.44%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-33.20%
CURRENT VS 3Y AVG
-64.29%
CURRENT VS 5Y AVG
-73.79%
CURRENT VS 10Y AVG
-58.73%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 866 covered companies
CURRENT VS SECTOR MEDIAN
+5605.97%
vs the sector median at left
Tactile Systems Technology, Inc.
Market Cap
$502.22M
Debt to Assets Ratio
5.14%
TTM Avg
7.69%
3Y Avg
14.38%
5Y Avg
19.60%
Market Cap
$507.01M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$507.38M
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$486.60M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$520.90M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tactile Systems Technology, Inc. (TCMD) | $502.22M | 5.14% | 7.69% | 14.38% | 19.60% |
| Crescent Biopharma, Inc. (CBIO)vs › | $507.01M | 0.01% | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $507.38M | 0.13% | N/A | N/A | N/A |
| Oculis Holding AG (OCS)vs › | $494.52M | 0.01% | N/A | N/A | N/A |
| 908 Devices Inc. (MASS)vs › | $510.79M | 0.02% | N/A | N/A | N/A |
| Altimmune, Inc. (ALT)vs › | $515.47M | 0.07% | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $486.78M | 0.66% | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.60M | 0.02% | N/A | N/A | N/A |
| Immix Biopharma, Inc. (IMMX)vs › | $520.90M | 0.00% | N/A | N/A | N/A |
| Alpha Teknova, Inc. (TKNO)vs › | $476.63M | 0.29% | N/A | N/A | N/A |
Debt/Assets
5.1%
Debt/Equity
0.06
Current Ratio
4.12
Interest Coverage
28.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 5.14% |
| 2026-03-31 | 5.58% |
| 2025-12-31 | 5.83% |
| 2025-09-30 | 6.46% |
| 2025-06-30 | 15.45% |
| 2025-03-31 | 15.57% |
| 2024-12-31 | 15.14% |
| 2024-09-30 | 16.18% |
| 2024-06-30 | 17.07% |
| 2024-03-31 | 18.01% |
| 2023-12-31 | 17.90% |
| 2023-09-30 | 23.25% |
| 2023-06-30 | 25.40% |
| 2023-03-31 | 25.73% |
| 2022-12-31 | 28.33% |
| 2022-09-30 | 29.61% |
| 2022-06-30 | 31.58% |
| 2022-03-31 | 32.74% |
| 2021-12-31 | 33.00% |
| 2021-09-30 | 32.28% |
| 2021-06-30 | 11.29% |
| 2021-03-31 | 11.91% |
| 2020-12-31 | 12.29% |
| 2020-09-30 | 13.90% |
| 2020-06-30 | 11.52% |
| 2020-03-31 | 10.57% |
| 2019-12-31 | 10.93% |
| 2019-09-30 | 20.02% |
| 2019-06-30 | 4.46% |
| 2019-03-31 | 3.05% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.02% |
| 2015-06-30 | 0.03% |
| 2014-12-31 | 0.04% |
